Skip to main content

CITADEL ADVISORS LLC

Position in RANI — Rani Therapeutics Holdings, Inc.

CIK 1423053 MIAMI, FL

Position in RANI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$487,916
+$487,916 QoQ
Shares Held
641,995
Ownership
0.461%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 67 holders
Holding Since
Mar 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RANI Over Time

Shares Held

Position Value (USD)

Derivatives in RANI

reported options exposure · as of Jun 30, 2026
CallValue
$12,008
CallShares
15,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. RANI ranks #270 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RANI

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,008 15,800
2026-06-30 $487,916 641,995
2026-03-31 $203,301 276,600
2025-12-31 $19,845 14,700
2025-12-31 $288,225 213,500
2025-09-30 $226,271 452,542
2025-06-30 $7,196 14,000
2025-06-30 $70,597 137,349
2025-03-31 $140,238 111,300
2025-03-31 $26,838 21,300
2024-12-31 $264,821 193,300
2024-12-31 $4,521 3,300
2024-12-31 $162,983 118,966
2024-09-30 $4,752 2,200
2024-09-30 $58,112 26,904
2024-09-30 $5,400 2,500
2024-06-30 $56,107 14,765
2024-06-30 $7,600 2,000
2024-06-30 $11,780 3,100
2024-03-31 $44,784 14,400
2024-03-31 $23,014 7,400
2024-03-31 $31,199 10,032
2023-06-30 $6,180 1,500
2023-06-30 $36,894 8,955
2023-06-30 $13,184 3,200
2023-03-31 $21,156 4,100
2023-03-31 $5,160 1,000
2023-03-31 $54,541 10,570